| Entry |
|
|---|
| Name |
Levobunolol (INN)
|
|---|
| Formula |
C17H25NO3
|
|---|
| Exact mass |
291.1834
|
|---|
| Mol weight |
291.3853
|
|---|
| Structure |
     |
|---|
| Activity |
Glaucoma treatment;
beta1-Adrenergic blocking [DS: H00612]
|
|---|
| Remark |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01ED Beta blocking agents
S01ED03 Levobunolol
D08115 Levobunolol (INN)
USP drug classification [BR:br08302]
Ophthalmic Agents
Ophthalmic Antiglaucoma Agents
Beta-Adrenergic Blocking Agents, Ophthalmic
Levobunolol
D08115 Levobunolol (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Levobunolol [ATC:S01ED03]
D08115 Levobunolol (INN)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Levobunolol [ATC:S01ED03]
D08115 Levobunolol (INN)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Levobunolol [ATC:S01ED03]
D08115 Levobunolol (INN)
 |
|---|
| Other DBs |
CAS: 47141-42-4 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 21
1 C8y C 21.1400 -18.2700
2 C8y C 19.8800 -17.5700
3 C8y C 22.3300 -17.5700
4 C1x C 21.1400 -19.6700
5 C8x C 19.8800 -16.1700
6 C5x C 18.6900 -18.2700
7 C8x C 22.3300 -16.1700
8 O2a O 23.5200 -18.2700
9 C1x C 19.8800 -20.3700
10 C8x C 21.1400 -15.4700
11 C1x C 18.6900 -19.6700
12 O5x O 17.5000 -17.5700
13 C1b C 24.7100 -17.5700
14 C1c C 25.9700 -18.2700
15 C1b C 27.1600 -17.5700
16 O1a O 25.9700 -19.6700
17 N1b N 28.3500 -18.2700
18 C1d C 29.6100 -17.5700
19 C1a C 30.8000 -18.2700
20 C1a C 29.6100 -16.1700
21 C1a C 30.8000 -16.8700
BOND 22
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 1
9 5 10 1
10 6 11 1
11 6 12 2
12 8 13 1
13 13 14 1
14 14 15 1
15 14 16 1 #Down
16 15 17 1
17 17 18 1
18 7 10 2
19 9 11 1
20 18 19 1
21 18 20 1
22 18 21 1
|
|---|
